Both in Testing Laboratories
NeoGenomics vs 20/20 Biolabs
Over the past year NEO returned +67.2% and AIDX returned −99.0%; their daily moves had a correlation of -0.86.
NEO +67.2% AIDX −99.0%Growth of $1, one year, split-adjusted
| Metric | NEO | AIDX |
|---|---|---|
| Price | $16.74 | $0.2290 |
| Market cap | $2.17B | $2.9M |
| Today | −3.68% | +7.51% |
| 1 month | −9.4% | −39.7% |
| 6 months | +86.0% | — |
| Year to date | +42.3% | — |
| 1 year | +72.8% | — |
| Revenue growth (YoY) | +11.4% | — |
| Gross margin | 46.2% | 41.7% |
| Net margin | −3.6% | −376.8% |
| P/E (TTM) | — | — |
| Price / sales | 2.7× | — |
| Net cash | -$241.3M | $4.5M |
| Dividend yield | — | — |
| Volatility (60d) | 52.8% | — |
| Short % of float | 11.3% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).